[Algorithm for the management of pulmonary arterial hypertension].

La Revue du praticien Pub Date : 2025-01-01
Marianne Riou, Sabina Salinas, Olivier Sitbon
{"title":"[Algorithm for the management of pulmonary arterial hypertension].","authors":"Marianne Riou, Sabina Salinas, Olivier Sitbon","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>ALGORITHM FOR THE MANAGEMENT OF PULMONARY ARTERIAL HYPERTENSION. The management of pulmonary arterial hypertension (PAH) has improved significantly in recent years due to advances in the understanding of the pathophysiological mechanisms of the disease, the development of innovative medications and the use of more aggressive therapeutic strategies. Because PAH is a rare disease, it must be managed in a pulmonary hypertension (PH) expert center. PAH management combines general measures, symptomatic treatments and «specific» therapies targeting the vasoconstriction/vasodilation and pro-proliferation/anti-proliferation balance of the pulmonary arteries. Despite major therapeutic advances in recent years, the prognosis for PAH remains poor and lung transplantation (or cardiopulmonary) transplantation is currently the only curative treatment available for the most severe patients.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 1","pages":"43-49"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"La Revue du praticien","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

ALGORITHM FOR THE MANAGEMENT OF PULMONARY ARTERIAL HYPERTENSION. The management of pulmonary arterial hypertension (PAH) has improved significantly in recent years due to advances in the understanding of the pathophysiological mechanisms of the disease, the development of innovative medications and the use of more aggressive therapeutic strategies. Because PAH is a rare disease, it must be managed in a pulmonary hypertension (PH) expert center. PAH management combines general measures, symptomatic treatments and «specific» therapies targeting the vasoconstriction/vasodilation and pro-proliferation/anti-proliferation balance of the pulmonary arteries. Despite major therapeutic advances in recent years, the prognosis for PAH remains poor and lung transplantation (or cardiopulmonary) transplantation is currently the only curative treatment available for the most severe patients.

肺动脉高压的处理算法。
肺动脉高压的处理算法。近年来,由于对该病病理生理机制的理解、创新药物的开发以及更积极的治疗策略的使用,肺动脉高压(PAH)的治疗有了显著改善。由于多环芳烃是一种罕见的疾病,它必须在肺动脉高压(PH)专家中心进行管理。PAH的治疗包括一般措施、对症治疗和针对肺动脉血管收缩/血管舒张和促增殖/抗增殖平衡的“特异性”治疗。尽管近年来治疗取得了重大进展,但PAH的预后仍然很差,肺移植(或心肺)移植是目前最严重患者唯一可治愈的治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信